Health Care & Life Sciences » Pharmaceuticals | IPCA Laboratories Ltd.

IPCA Laboratories Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
32,288
31,166
28,366
31,060
32,178
Cost of Goods Sold (COGS) incl. D&A
19,651
21,582
20,824
22,258
23,053
Gross Income
12,636
9,585
7,542
8,802
9,125
SG&A Expense
5,820
6,035
5,811
6,419
6,422
EBIT
6,599
3,313
-
-
2,587
Unusual Expense
10
18
105
31
48
Non Operating Income/Expense
120
410
105
631
520
Interest Expense
297
319
346
259
263
Pretax Income
6,306
3,611
1,166
2,621
2,905
Income Tax
1,524
1,019
204
675
511
Equity in Affiliates
3
49
31
-
-
Consolidated Net Income
4,785
2,542
931
1,945
2,394
Net Income
4,785
2,542
931
1,945
2,394
Net Income After Extraordinaries
4,785
2,542
931
1,945
2,394
Net Income Available to Common
4,785
2,542
931
1,945
2,394
EPS (Basic)
37.92
20.15
7.38
15.42
18.97
Basic Shares Outstanding
126
126
126
126
126
EPS (Diluted)
37.92
20.15
7.38
15.42
18.97
Diluted Shares Outstanding
126
126
126
126
126
EBITDA
7,630
5,109
3,227
3,965
4,364
Other Operating Expense
218
236
136
148
115
Non-Operating Interest Income
134
189
127
127
151
Equity in Affiliates (Pretax)
-
-
-
83
42

About IPCA Laboratories

View Profile
Address
142-AB, Kandivli Industrial Estate
Mumbai Maharashtra 400067
India
Employees -
Website http://www.ipcalabs.com
Updated 09/14/2018
Ipca Laboratories Ltd. engages in the manufacture, research, and development of pharmaceutical products. It offers active pharmaceuical ingredients such as Atenolol, Chloroquine Phosphate, Furosemide, Hydroxychloroquine Sulphate, Metoprolol Succinate, Metoprolol Tartrate, and Pyrantel Salts. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.